Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site
about
Molecular mechanistic associations of human diseasesDiscovery of novel PTP1B inhibitors with antihyperglycemic activity.Methyl effects on protein-ligand bindingFak56 functions downstream of integrin alphaPS3betanu and suppresses MAPK activation in neuromuscular junction growthKnowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor designProtein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.Macrocyclization of the ATCUN motif controls metal binding and catalysis.Identification of Bidentate Salicylic Acid Inhibitors of PTP1B.Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies.Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites.Computational Insight into Protein Tyrosine Phosphatase 1B Inhibition: A Case Study of the Combined Ligand- and Structure-Based Approach.Design, synthesis, and biological evaluation of bromophenol derivatives as protein tyrosine phosphatase 1B inhibitors.Copolymers of novel methacrylic and styrenic monomer based on the thiophene: synthesis, characterization, monomer reactivity ratios, thermal properties, and biological activity.
P2860
Q30496754-BCE93866-327B-4915-9C9D-58A240C173E1Q33557864-1FEE5878-6417-4D51-9470-4E844B9EC8D6Q35963565-AF1D0603-A2FA-4992-8AEA-50168CB1E0C9Q36957019-A1BB2176-EE46-4618-9A51-A9A8EF5705E8Q37610132-C18CB0A3-7FF4-4247-ADD9-21F4C604C346Q37855897-D5BB2E6A-414E-4284-AAAE-61A0F0C80DFBQ43223782-57727D09-5B16-46CB-BE93-9563454CA927Q43242949-ABDB1413-F63E-4F9F-89F3-9D984C2A203CQ45255796-88A35CCD-5B6B-438E-A870-0DEFCBEB5F9AQ47271707-4C8AB446-155C-4EE7-9AC0-1F9D97D9E72EQ47299327-681E075C-A21A-413F-B403-6CC1302702F3Q49462044-A046CB3B-690B-42F4-9ACF-2E466CAFE336Q50517677-536FA77C-DA82-4235-BEE6-9306559B1EBFQ51211727-DBC28F32-D9E1-4269-82F4-7406BBEDAB00
P2860
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structure-based optimization o ...... d phosphotyrosine binding site
@ast
Structure-based optimization o ...... d phosphotyrosine binding site
@en
Structure-based optimization o ...... d phosphotyrosine binding site
@nl
type
label
Structure-based optimization o ...... d phosphotyrosine binding site
@ast
Structure-based optimization o ...... d phosphotyrosine binding site
@en
Structure-based optimization o ...... d phosphotyrosine binding site
@nl
prefLabel
Structure-based optimization o ...... d phosphotyrosine binding site
@ast
Structure-based optimization o ...... d phosphotyrosine binding site
@en
Structure-based optimization o ...... d phosphotyrosine binding site
@nl
P2093
P356
P1476
Structure-based optimization o ...... d phosphotyrosine binding site
@en
P2093
Adam Shilling
Alessandro Moretto
Bruce C Follows
David V Erbe
Diane Joseph-McCarthy
Douglas P Wilson
Eva Binnun
James Tobin
P304
P356
10.1021/JM0702478
P407
P577
2007-09-20T00:00:00Z